author={William D. Fraser},
  journal={The Lancet},
  • W. Fraser
  • Published 1 April 1959
  • Medicine, Biology
  • The Lancet
Hyperparathyroidism is due to increased activity of the parathyroid glands, either from an intrinsic abnormal change altering excretion of parathyroid hormone (primary or tertiary hyperparathyroidism) or from an extrinsic abnormal change affecting calcium homoeostasis stimulating production of parathyroid hormone (secondary hyperparathyroidism). Primary hyperparathyroidism is the third most common endocrine disorder, with the highest incidence in postmenopausal women. Asymptomatic disease is… 

Figures from this paper

Hyperparathyroidism and Hypoparathyroidism

Parathyroid hormone and active vitamin D control calcium homeostasis; dysregulation of this system leads to abnormal calcium measurements and a spectrum of clinical disorders. Primary

A clinical perspective of parathyroid hormone related hypercalcaemia

A selection of distinct cases of primary hyperparathyroidism due to eutopic and ectopic parathyroid adenomas, as well as a case with a syndromic form of PHPT (multiple endocrine neoplasia type 1), and a cases with FHH type 1 due to a CASR inactivating mutation are presented.

Atypical parathyroid adenoma: clinical and anatomical pathologic features

Atypical parathyroid adenoma is a tumor that has characteristics both of typicalAdenoma andParathyroid carcinoma and the diagnosis is reached by excluding with strict methods the presence of malignancy criteria.

Parathyroid hormone independent hypercalcemia in adults.

Unusual recurrent renal secondary hyperparathyroidism caused by hyperplastic autograft with supernumerary parathyroid adenoma

Although rare, recurrent renal SHPT may be caused by a coexistence of both hyperfunctional autograft and SPG after TPTX+FAT, and the 99mTc-sestamibi parathyroid imaging with SPECT/CT is helpful to locate the culprits of recurrent renalSHPT before reoperation.

Postsurgical Evaluation of Secondary Nephrogenic Hyperparathyroidism

The convenient surgical removal of the hyperplastic parathyroid gland for postoperative recurrence supports tPTX+AT as the recommended treatment for relevant patients.

Screening for primary hyperparathyroidism in a tertiary stone clinic, a useful endeavor

Screening for primary hyperparathyroidism in patients evaluated in a tertiary referral setting support screening for 1HPT, and cost savings in screening are realized at 10 years.

Primary hyperparathyroidism presenting as a brown tumor with hypercalcemia crisis in a second-trimester pregnant woman

Maternal PHPT is rare and challenging to diagnose, causing life-threatening complications to mother and fetus, and any decision regarding surgery for a pregnant woman with primary hyperparathyroidism is more complex than in men or nonpregnant women.